TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer.

MLA

Reig, Òscar, et al. “TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-Resistant Prostate Cancer.” European Urology, vol. 70, no. 5, Nov. 2016, pp. 709–13. EBSCOhost, https://doi.org/10.1016/j.eururo.2016.02.034.

APA

Reig, Ò., Marín-Aguilera, M., Carrera, G., Jiménez, N., Paré, L., García-Recio, S., Gaba, L., Pereira, M. V., Fernández, P., Prat, A., & Mellado, B. (2016). TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer. European Urology, 70(5), 709–713. https://doi.org/10.1016/j.eururo.2016.02.034

Chicago

Reig, Òscar, Mercedes Marín-Aguilera, Gemma Carrera, Natalia Jiménez, Laia Paré, Susana García-Recio, Lydia Gaba, et al. 2016. “TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-Resistant Prostate Cancer.” European Urology 70 (5): 709–13. doi:10.1016/j.eururo.2016.02.034.